- ESSA Pharma (NASDAQ:EPIX) plans to issue 125M common shares at $0.20 per share. Investors also will have the option to receive one pre-funded five-year warrant in lieu of a common share.
- Net proceeds will fund the ongoing preclinical development of its next-generation Aniten compounds, debt service, working capital and general corporate purposes.
- Previously: ESSA Pharma prices stock offering at $0.20 (Dec. 13, 2017)